SANTA CLARA, Calif. and PUNE, India, Dec. 16, 2025 /PRNewswire/ -- Persistent Systems (BSE: 533179) and (NSE: PERSISTENT), a global Digital Engineering and Enterprise Modernization leader and ...
Safety and Efficacy of Pembrolizumab in Advanced, Programmed Death Ligand 1–Positive Cervical Cancer: Results From the Phase Ib KEYNOTE-028 Trial A total of 68,463 eligible patients underwent curative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results